Natural Alternatives International, Inc. Announces 2025 Q2 and YTD Results
The decrease in CarnoSyn ® beta-alanine royalty, licensing, and raw material sales revenue during the second quarter of fiscal 2025 was primarily due to a decrease in orders from existing customers.
JELD-WEN Holding: Cheap, But Navigating Considerable Headwinds
JELD-WEN Holding, Inc. shares fell 40% after a Q3 2024 miss, downward outlook revision, and industry challenges. Click here ...
Roku forecasts annual revenue above estimates on strong ad sales; shares jump
Roku forecast annual revenue above Wall Street estimates and topped fourth-quarter revenue expectations on Thursday, ...
GoDaddy produces mixed Q4 2024 financial results as revenue increases 9% year over year
GoDaddy (GDDY) produced mixed results when it released its fourth quarter 2024 financial numbers and outlook after the bell ...
The 3 Reasons Behind the Monster Confluent (NASDAQ:CFLT) Stock Rally
Shares of data streaming and cloud computing company Confluent (CFLT) jumped 25% on Wednesday as investors and analysts ...
Earnings call transcript: American Well Q4 2024 shows mixed results
American Well Corp (AMWL) recently released its fourth-quarter 2024 earnings, revealing steady revenue but challenges in visit numbers. The company posted a total Q4 revenue of $71 million, remaining ...
S&P 500 ekes out gain even as Powell urges caution on rates, tariffs weigh on markets: Live updates
The S&P 500 ended Tuesday near the flat line as investors digested cautious commentary from Federal Reserve Chair Jerome ...